Association of hepatitis C virus infection and diabetes in central Tunisia

Table 1 Epidemiological features of the study population in patients with diabetes and control group n (%)

	Diabetes patients (n = 1269)	Control group (n = 1315)	P
Gender
Female	817 (64.4)	890 (67.6)	0.06
Age
Mean age (yr)	55.6	46.9	< 10-3
Risk factors of HCV
Transfusion	157 (12.5)	185 (14.2)	0.2
History of surgery	592 (46.8)	551 (42.1)	0.01
Drug addiction	2 (0.2)	7 (0.5)	0.17
Scarification	247 (19.8)	301 (23.1)	0.04
Endoscopic investigation	276 (21.9)	308(23.6)	0.30
Alcoholism	164 (13)	178 (13.6)	0.65
History of hospitalization	875 (69.3)	785 (59.9)	< 10-3
Anti-HCV antibodies (+)	17 (1.3)	8 (0.6)	0.057

Table 2 Epidemiological features of the study population in type 2 DM patients and control group n (%)

	Type 2 DM patients (n = 1148)	Control group (n = 1315)	OR	P
Gender
Female	739 (65.2)	890 (67.6)	0.8 (0.73-1.2)	0.06
Age
Mean age (yr)	57 ± 10.4	46.9		< 10-3
Risk factors of HCV
Transfusion	136 (12.1)	185 (14.2)	0.83 (0.65-1.06)	0.2
History of surgery	528 (46.7)	551 (42.1)	1.18 (1.05-1.39)	0.01
Drug addiction	2 (0.2)	7 (0.5)	0.33 (0.05-1.78)	0.17
Scarification	222 (19.8)	301 (23.1)	0.81 (0.66-0.99)	0.04
Endoscopic investigation	248 (22)	308 (23.6)	0.90 (0.74-1.09)	0.30
Alcoholism	144 (12.8)	178 (13.6)	0.92 (0.78-1.17)	0.65
History of hospitalization	758 (67.1)	785 (59.9)	1.31 (1.11-1.55)	< 10-3
Anti-HCV antibodies (+)	16 (1.4)	8 (0.6)	2.31 (1.01-5.90)	0.04